Patent Number: 6,251,886

Title: Methods of using temozolomide in the treatment of cancers

Abstract: Methods are disclosed for treating cancer in a patient in need of such treating comprising administering temozolomide in an amount effective to achieve a clinical response wherein the temozolomide is administered in a microcrystalline suspension.

Inventors: Friedman; Henry S. (Durham, NC)

Assignee: Schering Corporation

International Classification: A61K 31/33 (20060101); A61K 031/33 ()

Expiration Date: 06/26/2018